Business Standard

Sunday, December 22, 2024 | 06:39 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19 vax export curbs may ease in two months: Adar Poonawalla

Poonawalla said easing the export restrictions is a government of India's decision, and he will go by what the Centre feels is appropriate

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute

Sohini Das Mumbai
Adar Poonawalla, chief executive officer of Serum Institute of India (SII), expects the restrictions on export of Covid vaccines to ease within two months, provided that India has created enough stockpile to weather a third wave.

Raw material supplies for the Novavax vaccine have improved compared to March, and SII plans to announce its monthly production plan in December, Poonawalla told the media on Friday.

“There was no ban on exports, but there were temporary restrictions, and rightly so. I think these will slowly ease in the next month or two, but I don’t want to venture a guess. But it will

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in